References
- Vedi S., Croucher P.I., Garrahan N.J., Compston J.E. Effect of hormone replacement therapy on canxellous bone microstructure in postmenopausal woman. Bone 1996 : 19 ; 69-72. https://doi.org/10.1016/8756-3282(96)00108-1
- Johansson A.G., Lindah E., Blum W.F., Kollerup G. Effect of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. J. Clin. Endocri. Met., 1996 : 81 ; 44-48. https://doi.org/10.1210/jc.81.1.44
- Canalis E. Mechanisms of glucocorticoid Action in Bone : Implications to glucocorticoid- induced Osteoporosis., J. Clin. Endocri. Met. 1996 : 81 ; 3441-3447. https://doi.org/10.1210/jc.81.10.3441
- Gopalakrishnan V, Vignesh R C, Arunakaran J, Aruldhas M M, Srinivasan J, Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages Biochem. Cell Biol. 2006 : 84 ; 93-101.
- Gundberg CM. Biochemical markers of bone formation. Clin Lab Med. 2000 : 20 ; 489-501.
- Ghayor C, Ehrbar M, San Miguel B, Grätz KW, Weber FE. cAMP enhances BMP2-signaling through PKA and MKP1- dependent mechanisms. Biochem Biophys Res Commun. 2009 : 381 ; 247-252. https://doi.org/10.1016/j.bbrc.2009.02.032
- Kim T, Kim K, Lee SH, So HS, Lee J, Kim N, Choi Y. Identification of LRRc17 as a negative regulator of receptor activator of NF-kappaB ligand(RANKL)-induced osteoclast differentiation. J Biol Chem. 2009 : 284 ; 15305-16.
- Takami M, Mochizuki A, Yamada A, Tachi K, Zhao B, Miyamoto Y, Anada T, Honda Y, Inoue T, Nakamura M, Suzuki O, Kamijo R. Osteoclast differentiation induced by synthetic octacalcium phosphate through RANKL expression in osteoblasts. Tissue Eng Part A. 2009 Jul 13.
- Miyake M, Arai N, Ushio S, Iwaki K, Ikeda M, Kurimoto M. Promoting effect of kaempferol on the differentiation and mineralization of murine pre-osteoblastic cell line MC3T3-E1. Biosci Biotechnol Biochem. 2003 : 67 ; 1199-1205. https://doi.org/10.1271/bbb.67.1199
- Mansell JP, Farrar D, Jones S, Nowghani M. Cytoskeletal reorganisation, 1alpha,25- dihydroxy vitamin D3 and human MG63 osteoblast maturation. Mol Cell Endocrinol. 2009 : 305 ; 38-46. https://doi.org/10.1016/j.mce.2009.02.032
- Benvennuti S., Tanini A., Frediani U., Bianchi S., Masi L., Casano R., Buffalino L., Serio M., Bradi M.L. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J . Bone Miner. Res. 1991 : 6 ; 987-996. https://doi.org/10.1002/jbmr.5650060913
- Gopalakrishnan V, Vignesh RC, Arunakaran J, Aruldhas MM, Srinivasan N., Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol. 2006 : 84 ; 93-101. https://doi.org/10.1139/O05-163
- Lee JW, Jhee O, Yuan H, Kim T, Kim D, Lee M, Om A, Lee B, Park SK, Kang J. Effect of Korean oriental medicine extract on bone mass as compared with alendronate in ovariectomized rats. J Med Food. 2005 : 8(3) ; 369-76. https://doi.org/10.1089/jmf.2005.8.369
- Tanaka H, Liang CT, Effect of platelet-derived growth factor on DNA synthesis and gene expression in bone marrow stromal cells derived from adult and old rats. J Cell Physiol. 1995 : 164 ; 367-75. https://doi.org/10.1002/jcp.1041640217
- Nemoto E, Shimonishi M, Nitta Y, Shimauchi H. The involvement of platelet-derived growth factor receptors and insulin-like growth factor-I receptors signaling during mineralized nodule formation by human periodontal ligament cells. J Periodontal Res. 2004 : 39 ; 388-97. https://doi.org/10.1111/j.1600-0765.2004.00750.x
- Kacena MA, Gundberg CM, Horowitz MC. A reciprocal regulatory interaction between megakaryocytes, bone cells, and hematopoietic stem cells. Bone. 2006 : 39 ; 978-84. https://doi.org/10.1016/j.bone.2006.05.019
- Deyama Y, Kikuiri T, Ohnishi G, Feng YG, Takeyama S, Hatta M, Yoshimura Y, Suzuki K. Histamine stimulates production of osteoclast differentiation factor/ receptor activator of nuclear factorkappaB ligand by osteoblasts. Biochem Biophys Res Commun. 2002 : 25 ; 240-6.
- Chikazu D, Katagiri M, Ogasawara T, Ogata N, Shimoaka T, Takato T, Nakamura K, Kawaguchi H. Regulation of osteoclast differentiation by fibroblast growth factor 2 : stimulation of receptor activator of nuclear factor kappaB ligand/ osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J Bone Miner Res. 2001 : 16 ; 2074-81. https://doi.org/10.1359/jbmr.2001.16.11.2074
- Sayegh RA, Stubblefield PG. Bone metabolism and the perimenopause overview, risk factors, screening, and osteoporosis preventive measures. Obstet Gynecol Clin North Am. 2002 : 29 ; 495-510. https://doi.org/10.1016/S0889-8545(02)00012-8